CNIO researchers assess melanoma progression with a new liquid biopsy technique

(Centro Nacional de Investigaciones Oncol ó gicas (CNIO)) Analysis of extracellular vesicles and circulating DNA from fluid obtained from the drainage implanted after surgery, normally disposed of as medical waste, detects melanoma patients with risk of recurrence and may help doctors decide who should undergo adjuvant therapyThe new technique might change the way melanoma patients are followed up.The upcoming goals are to verify whether liquid biopsy can be used to analyze blood directly and to explore its potential use in other tumors.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news